Enforcement Report - Week of November 13, 2024
13 Nov 2024 //
FDA
Enforcement Report - Week of November 6, 2024
06 Nov 2024 //
FDA
Dr. Reddy’s Q2 & H1FY25 Financial Results
05 Nov 2024 //
BUSINESSWIRE
Dr. Reddys`s Generics Dasatinib Receives Tentative Approval in US
04 Nov 2024 //
FDA
Dr Reddy`s launches medication to treat chronic constipation
29 Oct 2024 //
PRESS RELEASE
Dr. Reddy`s Launches Menopause Support Program For Employees
14 Oct 2024 //
BUSINESSWIRE
PE firms queue up for Novartis` Indian arm
12 Oct 2024 //
ECONOMICTIMES
Aurigene reports Positive Ph 1 trial for CAR-T cell therapy in India
09 Oct 2024 //
PRESS RELEASE
Dr Reddy`s sign voluntary licenses with Gilead for HIV drug
02 Oct 2024 //
PRESS RELEASE
Dr Reddy`s Generics Varenicline Tartrate Receives Approval in US
01 Oct 2024 //
FDA
Dr. Reddys`s Generics Varenicline Tartrate Receives Approval in US
01 Oct 2024 //
FDA
Dr. Reddy`s invests US$ 620 million in Switzerland subsidiary
30 Sep 2024 //
INDPHARMAPOST
UBS advises `selling` a bunch of pharma stocks
27 Sep 2024 //
CNBCTV
No observations by US FDA during plant inspection: DRL
21 Sep 2024 //
ECONOMIC TIMES
USFDA concludes GMP inspection at Dr Reddy’s R&D centre
20 Sep 2024 //
EXPRESSPHARMA
Dr Reddy`s Clarifies After Congress Alleges Benefit From Dhaval Buch Connection
11 Sep 2024 //
ECONOMICTIMES
Dr Reddy’s Glycemic Happiness Awareness initiative sets Guinness World Record
23 Aug 2024 //
EXPRESSPHARMA
Dr. Reddy`s, Aurigene, And Kainomyx Announce Potential Malaria Drug Partnership
20 Aug 2024 //
PRESS RELEASE
Dr Reddy`s gets EIR from USFDA for Visakhapatnam units
12 Aug 2024 //
ECONOMICTIMES
Dr. Reddy lab`s Generics Prednisone Receives Tentative Approval in US
08 Aug 2024 //
FDA
Dr Reddy`s invests Rs 734 crore in JV with Nestle India
04 Aug 2024 //
ECONOMICTIMES
India`s MedPlus Health posts Q1 profit surge on strong organised sector growth
02 Aug 2024 //
REUTERS
Dr. Reddy’s receives positive opinion from EMA for Rituximab biosimilar
29 Jul 2024 //
PRESS RELEASE
Dr Reddys Laboratories posts Q1 FY25 consolidated PAT at Rs. 1,392 Cr
29 Jul 2024 //
PRESS RELEASE
Dr. Reddy’s Q1FY25 Financial Results
27 Jul 2024 //
PRESS RELEASE
Dr Reddy`s inks licensing pact with Takeda to sell gastrointestinal drug
20 Jul 2024 //
PRESS RELEASE
Dr. Reddy`s Signs Licensing Deal With Takeda For Vonoprazan
19 Jul 2024 //
PRESS RELEASE
Enforcement Report - Week of July 10, 2024
10 Jul 2024 //
FDA
Aurigene & Edity Enter Strategic Collaboration in Cell Therapy
03 Jul 2024 //
PRESS RELEASE
Zydus and Dr. Reddy`s announce agreement for marketing of Pertuzumab biosimilar
29 Jun 2024 //
PRESS RELEASE
Dr Reddy`s Generic Midostaurin Receives Approval in US
28 Jun 2024 //
FDA
Haleon sells nicotine replacement unit to Dr. Reddy`s for $633M
27 Jun 2024 //
PRESS RELEASE
Dr. Reddy`s Laboratories Limited CTO -- Unit 6
20 Jun 2024 //
FDA
Dr. Reddy`s shares rise as arm signs license agreement with Ingenus Pharma
12 Jun 2024 //
MONEYCONTROL
Briefs: Dr. Reddy`s and Ami Organics
07 Jun 2024 //
INDIANPHARMAPOST
Enforcement Report - Week of June 5, 2024
05 Jun 2024 //
FDA
Dr Reddys Labs` Generic Arformoterol Tartrate Receives Approval in the U.S
03 Jun 2024 //
FDA
Aurigene Opens Biologics Facility For Process, Clinical Manufacturing
03 Jun 2024 //
PRESS RELEASE
Enforcement Report - Week of May 29, 2024
29 May 2024 //
FDA
Dr. Reddy`s: Milan Kalawadia Appointed CEO North America
28 May 2024 //
BUSINESSWIRE
Indian drugmakers to see FY25 revenue boost in key US market
28 May 2024 //
REUTERS
Dr. Reddy’s and Novartis sign distribution agreement for anti-diabetes products
27 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Personalised medicine is a new thing fast gaining momentum: CEO, DRL
24 May 2024 //
PHARMABIZ
Alvotech, Dr. Reddy`s ink pact for commercialisation of denosumab
21 May 2024 //
PRESS RELEASE
U.S. FDA issues two observations for Dr. Reddy’s formul facilities in Vizag
17 May 2024 //
THEHINDU
Enforcement Report - Week of May 15, 2024
15 May 2024 //
FDA
India`s Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
11 May 2024 //
REUTERS
Dr Reddys Labs` Generic Vasopressin Receives Approval in the U.S
08 May 2024 //
FDA
Dr Reddy`s healthy Q4 results fail to impress brokerages
08 May 2024 //
MONEYCONTROL
Dr Reddy’s to launch over 20 products in US in FY25
08 May 2024 //
MONEYCONTROL
Dr. Reddy’s Q4 & Full Year FY24 Financial Results
07 May 2024 //
PRESS RELEASE
Dr Reddy`s Labs CFO Parag Agarwal to retire on July 31, MV Narasimham elevated
07 May 2024 //
MONEYCONTROL
Dr Reddys Labs` Generic Edaravone Receives Approval in the U.S
06 May 2024 //
FDA
Dr. Reddy`s launches Doxycycline Capsules, 40 mg in US
03 May 2024 //
PRESS RELEASE
Dr Reddy’s, Sun, Cipla and Biocon look to recreate Ozempic magic in India
28 Apr 2024 //
ECONOMICTIMES
Nestle India profit beats estimates on strong demand; forms JV with Dr. Reddy`s
24 Apr 2024 //
PRESS RELEASE
Dr Reddys Labs` Generic Calcitonin Salmon Receives Approval in the U.S
11 Apr 2024 //
FDA
Dr Reddy`s launches migraine management device in Europe
11 Apr 2024 //
PRESS RELEASE